As the CX Lead for Emerging Markets at Pfizer, Anna Batur plays a pivotal role in shaping the customer experience landscape across diverse and dynamic regions. With a decade of experience in the pharmaceutical industry, she has adeptly bridged the gap between commercial and digital...
As the CX Lead for Emerging Markets at Pfizer, Anna Batur plays a pivotal role in shaping the customer experience landscape across diverse and dynamic regions. With a decade of experience in the pharmaceutical industry, she has adeptly bridged the gap between commercial and digital realms, leveraging her expertise to enhance customer interactions with Pfizer's brands. Anna's current focus is on measuring and optimizing the customer experience (CX) that Pfizer delivers across various countries within the Emerging Markets region. This involves not only gathering and analyzing insights but also translating them into actionable strategies that empower local teams to improve customer perceptions and engagement.
Anna's strategic approach is rooted in her extensive skills in market research, customer relations, and product management. By employing advanced methodologies to assess customer feedback and satisfaction, she identifies key areas for improvement and collaborates with cross-functional teams to implement innovative solutions. Her ability to foster knowledge transfer and training initiatives ensures that insights are effectively communicated and utilized, driving a culture of continuous improvement within the organization.
Key projects under Anna's leadership have included the development of tailored CX frameworks that address the unique challenges faced by emerging markets, as well as the implementation of digital tools that enhance customer interactions. By focusing on channel sales and product marketing, she has successfully aligned Pfizer's offerings with the needs and expectations of customers, ultimately contributing to stronger brand loyalty and market presence. Anna's commitment to excellence in customer experience not only enhances Pfizer's reputation but also reinforces the company's mission to deliver better health outcomes across the globe.
